{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "27241-126",
      "generic_name": "Ranolazine",
      "labeler_name": "Ajanta Pharma USA Inc.",
      "brand_name": "Ranolazine",
      "active_ingredients": [
        {
          "name": "RANOLAZINE",
          "strength": "1000 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "27241-126-02",
          "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-02)",
          "marketing_start_date": "20190823",
          "sample": false
        },
        {
          "package_ndc": "27241-126-05",
          "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-05)",
          "marketing_start_date": "20210714",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Ajanta Pharma USA Inc."
        ],
        "rxcui": [
          "616749",
          "728231"
        ],
        "spl_set_id": [
          "8bfd1a61-547a-4847-ae4e-480b17da6272"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0327241125027",
          "0327241126024"
        ],
        "nui": [
          "N0000175427",
          "N0000190114",
          "N0000185503",
          "N0000182137",
          "N0000187061"
        ],
        "pharm_class_epc": [
          "Anti-anginal [EPC]"
        ],
        "pharm_class_moa": [
          "Cytochrome P450 3A Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Cytochrome P450 2D6 Inhibitors [MoA]",
          "Organic Cation Transporter 2 Inhibitors [MoA]"
        ],
        "unii": [
          "A6IEZ5M406"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, EXTENDED RELEASE",
      "spl_id": "933f695e-e4f4-4c75-80fc-aea9a30aa13d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20190823",
      "product_id": "27241-126_933f695e-e4f4-4c75-80fc-aea9a30aa13d",
      "application_number": "ANDA210054",
      "brand_name_base": "Ranolazine",
      "pharm_class": [
        "Anti-anginal [EPC]",
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Organic Cation Transporter 2 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}